These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 29316564)
21. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States. Patel AR; Dombrovskiy VY; Vogel TR Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855 [TBL] [Abstract][Full Text] [Related]
22. The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting. Breet NJ; de Jong C; Bos WJ; van Werkum JW; Bouman HJ; Kelder JC; Bergmeijer TO; Zijlstra F; Hackeng CM; Ten Berg JM Thromb Haemost; 2014 Dec; 112(6):1174-81. PubMed ID: 25231776 [TBL] [Abstract][Full Text] [Related]
23. Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis. Chan PH; Huang D; Yip PS; Hai J; Tse HF; Chan TM; Lip GY; Lo WK; Siu CW Europace; 2016 May; 18(5):665-71. PubMed ID: 26504109 [TBL] [Abstract][Full Text] [Related]
24. Effect of Estimated Glomerular Filtration Rate Decline on the Efficacy and Safety of Clopidogrel With Aspirin in Minor Stroke or Transient Ischemic Attack: CHANCE Substudy (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events). Zhou Y; Pan Y; Wu Y; Zhao X; Li H; Wang D; Johnston SC; Liu L; Wang C; Meng X; Wang Y; Wang Y; Stroke; 2016 Nov; 47(11):2791-2796. PubMed ID: 27738237 [TBL] [Abstract][Full Text] [Related]
26. New insights into stroke in chronic kidney disease. Khella SL Adv Chronic Kidney Dis; 2008 Oct; 15(4):338-46. PubMed ID: 18805379 [TBL] [Abstract][Full Text] [Related]
27. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk. Potpara TS; Lip GY Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958 [TBL] [Abstract][Full Text] [Related]
28. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study. Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028 [TBL] [Abstract][Full Text] [Related]
29. Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry. Boriani G; Proietti M; Laroche C; Fauchier L; Marin F; Nabauer M; Potpara T; Dan GA; Kalarus Z; Diemberger I; Tavazzi L; Maggioni AP; Lip GYH; ; Europace; 2018 May; 20(5):747-757. PubMed ID: 29016832 [TBL] [Abstract][Full Text] [Related]
30. Challenges in comparing the non-vitamin K antagonist oral anticoagulants for atrial fibrillation-related stroke prevention. Camm AJ; Fox KAA; Peterson E Europace; 2018 Jan; 20(1):1-11. PubMed ID: 29040518 [TBL] [Abstract][Full Text] [Related]
31. Pathophysiology of atrial fibrillation and chronic kidney disease. Ding WY; Gupta D; Wong CF; Lip GYH Cardiovasc Res; 2021 Mar; 117(4):1046-1059. PubMed ID: 32871005 [TBL] [Abstract][Full Text] [Related]
32. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Dillinger JG; Aleil B; Cheggour S; Benhamou Y; Béjot Y; Marechaux S; Delluc A; Bertoletti L; Lellouche N Arch Cardiovasc Dis; 2018 Feb; 111(2):85-94. PubMed ID: 28988597 [TBL] [Abstract][Full Text] [Related]
33. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration. Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192 [TBL] [Abstract][Full Text] [Related]
34. Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination? Garg L; Chen C; Haines DE Int J Cardiol; 2016 Nov; 222():47-50. PubMed ID: 27472258 [TBL] [Abstract][Full Text] [Related]
35. Aspirin and cardiovascular primary prevention in non-endstage chronic kidney disease: A meta-analysis. Major RW; Oozeerally I; Dawson S; Riddleston H; Gray LJ; Brunskill NJ Atherosclerosis; 2016 Aug; 251():177-182. PubMed ID: 27341534 [TBL] [Abstract][Full Text] [Related]
36. Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study. Loo SY; Coulombe J; Dell'Aniello S; Brophy JM; Suissa S; Renoux C BMJ Open; 2018 Jan; 8(1):e019638. PubMed ID: 29371284 [TBL] [Abstract][Full Text] [Related]
37. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M; Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865 [TBL] [Abstract][Full Text] [Related]